Announcements Trials

Browse Landscape Eligibility

Clinical Trials

0 trials

Recent Start date Enrollment

Has results × Liver Neoplasms × infigratinib × Clear all

Sponsor

Conditions

Glioblastoma 2 Cholangiocarcinoma 2 Upper Tract Urothelial Carcinomas 1 Squamous Cell Carcinoma of Head and Neck 1 Renal Pelvis and Ureter Urothelial Carcinoma 1 Papillomavirus Infections 1 Neoplasm Metastasis 1 Nasopharyngeal Neoplasms 1 Melanoma 1 Hematologic Neoplasms 1 Glioma 1 Advanced Gastrointestinal Stromal Tumor (GIST) 1

Interventions

Sorafenib 22 Bevacizumab 10 Capecitabine 6 Radiofrequency Ablation 5 Oxaliplatin 5 Fluorouracil 5 Doxorubicin 5 pembrolizumab 4 Sunitinib 4 Radiosurgery 4 Cisplatin 4 Ramucirumab 3 Radiotherapy 3 Leucovorin 3 Erlotinib Hydrochloride 3 Carboplatin 3 tremelimumab 2 spartalizumab 2 perflutren 2 derazantinib 2 carotuximab 2 Nivolumab 2 Mitomycin 2 Magnetic Resonance Spectroscopy 2 Magnetic Resonance Imaging 2 Ipilimumab 2 Immunohistochemistry 2 Gemcitabine 2 Folfox protocol 2 Fluorodeoxyglucose F18 2

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

No trials found.

Data powered by HemOnc (CC BY 4.0) Colophon ⚡